Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7F7W

JAK2-JH2

Summary for 7F7W
Entry DOI10.2210/pdb7f7w/pdb
DescriptorTyrosine-protein kinase JAK2, 2-((1-(2-fluoro-4-((4-(1-isopropyl-1H-pyrazol-4-yl)-5-methylpyrimidin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)ethan-1-ol (3 entities in total)
Functional Keywordsjak2, jh2, inhibitor, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight64199.84
Authors
Niu, L. (deposition date: 2021-06-30, release date: 2022-03-30, Last modification date: 2023-11-29)
Primary citationHu, M.,Yang, T.,Yang, L.,Niu, L.,Zhu, J.,Zhao, A.,Shi, M.,Yuan, X.,Tang, M.,Yang, J.,Pei, H.,Yang, Z.,Chen, Q.,Ye, H.,Niu, T.,Chen, L.
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms.
Blood Cancer J, 12:37-37, 2022
Cited by
PubMed: 35256594
DOI: 10.1038/s41408-022-00628-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.83 Å)
Structure validation

221371

PDB entries from 2024-06-19

PDB statisticsPDBj update infoContact PDBjnumon